← Evidence map

ReviewBiomolecules2024

CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis.

Andrew R Pachner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39766248